Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Craniopharyngioma × trametinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 34 Carcinoma, Non-Small-Cell Lung 9 Thyroid Neoplasms 8 Thyroid Carcinoma, Anaplastic 8 Neoplasms 8 Colorectal Neoplasms 8 Neoplasm Metastasis 6 Multiple Myeloma 5 Glioma 5 Pancreatic Neoplasms 4 Brain Neoplasms 4 Recurrence 3 Neurofibromatosis 1 3 Lung Neoplasms 3 Hematologic Neoplasms 3 Ameloblastoma 3 Thyroid Cancer, Papillary 2 Skin Neoplasms 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neurofibroma, Plexiform 2 Myelodysplastic Syndromes 2 Meningioma 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid, Acute 2 Colonic Neoplasms 2 Breast Neoplasms 2 Astrocytoma 2

Interventions

Surgical Procedures, Operative 3 Exenatide 3 tocilizumab 2 Surveys and Questionnaires 2 Mental Status and Dementia Tests 2 Magnetic Resonance Spectroscopy 2 Donepezil 2 trametinib 1 tozuleristide 1 tovorafenib 1 temsirolimus 1 gallium Ga 68 dotatate 1 dabrafenib 1 cobimetinib 1 binimetinib 1 antineoplaston AS 2-1 1 antineoplaston A10 1 anlotinib 1 Vemurafenib 1 Tumor Burden 1 Transurethral Resection of Bladder 1 Thalidomide 1 Temozolomide 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Radiation 1 Qsymia 1 Proton Therapy 1 Photochemotherapy 1 Phentermine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05525273 2024-02-14

Swecranio

Skane University Hospital

Phase 2 Recruiting

Craniopharyngioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡